$86 Million

Verrica Pharmaceuticsls

Initial Public Offering

Bookrunner, June 2018

Verrica Pharmaceuticals is a clinical-stage medical dermatology company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs.